• OPEN AN ACCOUNT
Indian Indices
Nifty
18,599.00 5.15
(0.03%)
Sensex
62,896.95 104.07
( 0.17%)
Bank Nifty
44,164.55 62.90
( 0.14%)
Nifty IT
28,689.05 -549.70
( -1.88%)
Global Indices
Nasdaq
13,276.42 46.99
(0.36%)
Dow Jones
33,573.28 10.42
(0.03%)
Hang Seng
19,099.28 -9.22
(-0.05%)
Nikkei 225
32,506.78 289.35
(0.90%)
Forex
USD-INR
82.54 0.14
(0.17%)
EUR-INR
88.32 0.10
(0.12%)
GBP-INR
102.50 -0.04
(-0.04%)
JPY-INR
0.59 0.00
(0.20%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
305.2452925
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
30.18
78475.85
EPS(TTM)
Face Value()
Div & Yield %
32.22
2
0.87
 

cipla ltd
Cipla Ltd - Announcement under Regulation 30 (LODR)-Diversification / Disinvestment
Mar 14,2023
In compliance with the provisions of Regulation 30 of the SEBI Listing Regulations we hereby notify that the Company and its wholly owned subsidiaries Cipla (EU) Limited UK and Meditab Holdings Limited Mauritius have entered into a Share Purchase Agreement with Africa Capitalworks SSA 3 on 14th March 2023 for sale of 51.18% stake held in Cipla Quality Chemical Industries Limited (CQCIL) Uganda. Subsequent to the sale CQCIL will cease to be a subsidiary of the Company. Details required to be disclosed under the SEBI Listing Regulations 2015 read with Circular No. CIR/CFD/CMD/4/2015 dated 9th September 2015 have been provided in Annexure - I to this letter.